Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Boehringer Ingelheim
Purpose:
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Age = 18 years.
Women and men with locally advanced, metastatic or locally recurrent NSCLC with histology of adenocarcinoma.
Signed and dated written informed consent.
Vargatef ® is initiated and administered in accordance with the SPC.
Available fixed and paraffin embedded (FPE) tumour tissue routinely obtained at diagnosis and/or at re-biopsy before the initiation of the first line treatment (either block or slides, minimum of 10 slides and up to 20 slides if possible at 5µm thickness).
You may not be if
Any contraindication to Vargatef® or docetaxel as specified in their respective labels.
Vargatef® initiated more than 7 days prior to inclusion in this NIS.
Patients participating simultaneously in a clinical trial.
